Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Founders Advantage Capital Corp. (FCF.V)ScotGemsBlackRock Income and Growth Investment TrustFirst Property GroupBraveheart Investment Group
SymbolCVE:FCFLON:SGEMLON:BRIGLON:FPOLON:BRH
Price Information
Current PriceC$3.15GBX 73.50GBX 170GBX 32.50GBX 72
52 Week RangeBuyN/AN/AN/AN/A
MarketRank™
Overall Score0.50.71.21.41.0
Analysis Score0.00.00.00.00.0
Community Score1.93.52.82.83.5
Dividend Score0.80.01.72.51.7
Ownership Score0.00.01.70.00.0
Earnings & Valuation Score0.00.00.01.90.0
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapC$38.08 million£39.35 million£37.43 million£35.87 million£27.57 million
BetaN/AN/AN/AN/AN/A
Average Volume105,40980,83213,459107,7651,609,751
Sales & Book Value
Annual RevenueC$81.50 millionN/A£-6,869,000.00£14.54 million£952,323.00
Price / Sales1.47N/A-5.452.4728.95
CashflowC$0.25 per shareN/AGBX 7.30 per shareGBX 18.68 per shareGBX 1.81 per share
Price / Cash12.60N/A23.291.7439.74
Book ValueC$1.92 per shareN/AGBX 161.40 per shareGBX 42.70 per shareGBX 9.50 per share
Price / Book1.64N/A0.010.010.08
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.02)N/AGBX (32.80)GBX 2.70GBX (0.10)
Trailing P/E RatioN/A0.00N/A12.04N/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AGBX 0.07GBX 0.02N/A
Dividend YieldN/AN/A0.04%0.05%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A 0.62%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio72.88%N/A10.99%88.08%0.74%
Current Ratio0.69%N/A0.52%1.26%4.01%
Quick Ratio0.56%N/A0.52%0.76%2.55%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/AN/AN/A637
Shares Outstanding38.08 million53.53 million22.02 million110.38 million38.30 million
Next Earnings Date4/22/2021 (Estimated)N/A6/21/2021 (Estimated)6/21/2021 (Estimated)N/A
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Insider Selling: Braveheart Investment Group plc (LON:BRH) Insider Sells 150,000 Shares of StockInsider Selling: Braveheart Investment Group plc (LON:BRH) Insider Sells 150,000 Shares of Stock
americanbankingnews.com - April 9 at 10:18 AM
AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolutionAIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution
lse.co.uk - April 1 at 8:29 AM
Braveheart Investment Group plc (LON:BRH) Insider Trevor Brown Sells 1,419,189 SharesBraveheart Investment Group plc (LON:BRH) Insider Trevor Brown Sells 1,419,189 Shares
americanbankingnews.com - April 1 at 4:28 AM
Braveheart Inv Group - Directorate ChangeBraveheart Inv Group - Directorate Change
proactiveinvestors.co.uk - March 29 at 10:12 AM
Braveheart Investment Group soars as investee COVID-19 test exceeds expectationsBraveheart Investment Group soars as investee COVID-19 test exceeds expectations
proactiveinvestors.co.uk - March 26 at 2:34 PM
Braveheart Inv Group - Replacement: Exercise of Options & Block AdmissionBraveheart Inv Group - Replacement: Exercise of Options & Block Admission
proactiveinvestors.co.uk - March 5 at 6:14 PM
Braveheart Investments Paraytec present their operational Covid-19 sample testing pipelineBraveheart Investments' Paraytec present their operational Covid-19 sample testing pipeline
proactiveinvestors.co.uk - March 1 at 1:48 PM
Braveheart Investment says Paraytec clinical sample pipeline now fully operationalBraveheart Investment says Paraytec clinical sample pipeline now fully operational
proactiveinvestors.co.uk - March 1 at 8:47 AM
Braveheart Inv Group - Share price movementBraveheart Inv Group - Share price movement
proactiveinvestors.co.uk - February 16 at 8:01 AM
Braveheart Investment says nothing to add after share price rocketsBraveheart Investment says nothing to add after share price rockets
proactiveinvestors.co.uk - February 16 at 8:01 AM
Braveheart Inv Group - Further update re Paraytec LimitedBraveheart Inv Group - Further update re Paraytec Limited
proactiveinvestors.co.uk - January 30 at 4:09 PM
Braveheart says Paraytecs Covid-19 diagnostic tool programme still on trackBraveheart says Paraytec's Covid-19 diagnostic tool programme still on track
proactiveinvestors.co.uk - January 29 at 7:37 AM
University of Sheffield team on track to deliver robust test to control global spread of coronavirusUniversity of Sheffield team on track to deliver 'robust test' to control global spread of coronavirus
yorkshirepost.co.uk - January 29 at 7:37 AM
Braveheart says Paraytecs coronavirus diagnostic tool programme still on trackBraveheart says Paraytec's coronavirus diagnostic tool programme still on track
proactiveinvestors.co.uk - January 29 at 7:37 AM
Remote Monitored Systems Investor Says Response To Concerns "Positive"Remote Monitored Systems Investor Says Response To Concerns "Positive"
lse.co.uk - December 31 at 10:32 PM
Director Deals - Braveheart Investment Group PLC (BRH)Director Deals - Braveheart Investment Group PLC (BRH)
stockmarketwire.com - December 7 at 3:49 AM
Braveheart Investment Group Pharm2Farm designs antiviral face mask to kill COVID-19Braveheart Investment Group Pharm2Farm designs antiviral face mask to kill COVID-19
proactiveinvestors.co.uk - October 28 at 6:53 PM
Braveheart value rockets as coronavirus shines light on portfolioBraveheart value rockets as coronavirus shines light on portfolio
proactiveinvestors.com.au - October 28 at 1:53 PM
Braveheart Investment says investee company expects to be selling new, specially-coated anti-COVID-19 masks by the end of the yearBraveheart Investment says investee company expects to be selling new, specially-coated anti-COVID-19 masks by the end of the year
proactiveinvestors.co.uk - October 24 at 7:32 PM
MARKET REPORT: How French pharma firm Novacyt has turned £10,000 into nearly £1m supplying the world with Covid testsMARKET REPORT: How French pharma firm Novacyt has turned £10,000 into nearly £1m supplying the world with Covid tests
msn.com - October 23 at 11:54 PM
Braveheart soars as investee Paraytec completes proof of concept trials for coronavirus testBraveheart soars as investee Paraytec completes proof of concept trials for coronavirus test
proactiveinvestors.co.uk - October 17 at 11:25 PM
Braveheart Investment Group PLCBraveheart Investment Group PLC
bloomberg.com - October 15 at 11:38 PM
Braveheart Investment notes short delay in planned testing of investee firm, Pharm 2 Farms anti-viral face mask materialBraveheart Investment notes short delay in planned testing of investee firm, Pharm 2 Farm's anti-viral face mask material
proactiveinvestors.co.uk - October 10 at 8:53 AM
Braveheart updates on progress of investee firm ParaytecBraveheart updates on progress of investee firm Paraytec
proactiveinvestors.co.uk - October 8 at 12:49 PM
Braveheart Inv Group - Second Price Monitoring ExtnBraveheart Inv Group - Second Price Monitoring Extn
proactiveinvestors.co.uk - October 1 at 9:36 AM
DateCompanyBrokerageAction
10/6/2020Founders Advantage Capital Corp. (FCF.V)Clarus SecuritiesReiterated Rating
8/5/2020Founders Advantage Capital Corp. (FCF.V)DesjardinsUpgrade
11/20/2018Founders Advantage Capital Corp. (FCF.V)Raymond JamesDowngrade
8/23/2018Founders Advantage Capital Corp. (FCF.V)Canaccord GenuityLower Price Target
(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.